menu
    • menu

    Company profile for 3T Biosciences

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    3T is an immunotherapy company developing next-generation, transformative therapies for the treatment of solid tumors and other immune-mediated diseases in broad patient populations. By leveraging the power of the immune system to recognize, target, and destroy cancer cells, 3T's technology is advancing the development of next-generation therapies that have the potential to be safer, more effective, and even curative for di...
    3T is an immunotherapy company developing next-generation, transformative therapies for the treatment of solid tumors and other immune-mediated diseases in broad patient populations. By leveraging the power of the immune system to recognize, target, and destroy cancer cells, 3T's technology is advancing the development of next-generation therapies that have the potential to be safer, more effective, and even curative for difficult-to-treat cancers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    3T BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    201 Haskins Way, 5th Floor South San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://3tbiosciences.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/3tbiosciences/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    3T Biosciences Names Kharabi as CMO, Knudsen to Board
    3T Biosciences Names Kharabi as CMO, Knudsen to Board

    06 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260106663539/en/3T-Biosciences-Announces-Appointments-of-Behzad-Kharabi-M.D.-as-Chief-Medical-Officer-and-Parker-Institute-for-Cancer-Immunotherapy-PICI-CEO-Karen-Knudsen-MBA-Ph.D.-to-Board-of-Directors

    BUSINESSWIRE
    06 Jan 2026
    Share Share
    Boehringer doubles down on T-cell based discovery partnership with 3T
    Boehringer doubles down on T-cell based discovery partnership with 3T

    05 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/boehringer-ingelheim-and-3t-biosciences-enter-into-a-second-partnership-to-develop-next-generation-cancer-immunotherapies-302024856.html

    PR NEWSWIRE
    05 Jan 2024
    Share Share
    Boehringer Ingelheim and 3T Biosciences enter into a second partnership
    Boehringer Ingelheim and 3T Biosciences enter into a second partnership

    04 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/boehringer-ingelheim-and-3t-biosciences-enter-into-a-second-partnership-to-develop-next-generation-cancer-immunotherapies-302024856.html

    PR NEWSWIRE
    04 Jan 2024
    Share Share
    3T Biosciences Expands Leadership Team With Bryan Irving as CSO
    3T Biosciences Expands Leadership Team With Bryan Irving as CSO

    25 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/3t-biosciences-expands-leadership-team-with-bryan-irving-phd-as-chief-scientific-officer-to-progress-tumor-specific-therapies-to-clinic-301965135.html

    PR NEWSWIRE
    25 Oct 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search